AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
La batalla entre científicos por el fármaco del alzhéimer: ¿cura prometedora o riesgo inaceptable?
Hoy en EL PAÍS
Controversia sobre el fármaco del Alzheimer
Este capítulo explora la polémica en torno a un nuevo fármaco para el tratamiento del alzhéimer y la presión para su aprobación en Europa. Se destaca la necesidad de mayor financiación para la investigación del alzhéimer y las implicaciones de la reticencia europea frente a la innovación médica.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode